NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $336,491 | +1.0% | 3,303 | 0.0% | 0.15% | +0.7% |
| Q2 2023 | $333,306 | +9.7% | 3,303 | 0.0% | 0.15% | +5.5% |
| Q1 2023 | $303,876 | +4.6% | 3,303 | +3.1% | 0.14% | -3.3% |
| Q4 2022 | $290,576 | +19.6% | 3,203 | 0.0% | 0.15% | +5.6% |
| Q3 2022 | $243,000 | -7.3% | 3,203 | +3.2% | 0.14% | -3.4% |
| Q2 2022 | $262,000 | -4.4% | 3,103 | -0.7% | 0.15% | 0.0% |
| Q1 2022 | $274,000 | +0.4% | 3,126 | 0.0% | 0.15% | 0.0% |
| Q4 2021 | $273,000 | +6.6% | 3,126 | 0.0% | 0.15% | 0.0% |
| Q3 2021 | $256,000 | -6.2% | 3,126 | +4.3% | 0.15% | -11.4% |
| Q2 2021 | $273,000 | +18.7% | 2,996 | +11.1% | 0.17% | +12.2% |
| Q1 2021 | $230,000 | -34.5% | 2,696 | -27.5% | 0.15% | -31.2% |
| Q4 2020 | $351,000 | +12.1% | 3,719 | +3.3% | 0.22% | +0.5% |
| Q3 2020 | $313,000 | +17.2% | 3,601 | +17.4% | 0.21% | +4.9% |
| Q2 2020 | $267,000 | -1.8% | 3,066 | +6.5% | 0.20% | +0.5% |
| Q4 2019 | $272,000 | – | 2,879 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |